Suppr超能文献

促炎转录因子与糖皮质激素之间的相互作用。

Cross-talk between pro-inflammatory transcription factors and glucocorticoids.

作者信息

Adcock I M, Caramori G

机构信息

Thoracic Medicine, National Heart and Lung Institute, Imperial College School of Science, Technology and Medicine, London, United Kingdom.

出版信息

Immunol Cell Biol. 2001 Aug;79(4):376-84. doi: 10.1046/j.1440-1711.2001.01025.x.

Abstract

Asthma is a chronic inflammatory disease of the airway that is characterized by cellular infiltration and activation. These processes are induced by overexpression of chemokines and cytokines, such as eotaxin, IL-1beta and GM-CSF. These mediators are downstream targets for the transcription factors activator protein-1 (AP-1) and nuclear factor-kappaB (NF-kappaB), which control the expression of most immunomodulatory genes and whose activity and expression are elevated in asthma. Glucocorticoids are the most effective anti-inflammatory drugs used in the treatment of chronic inflammatory diseases such as asthma. They act by binding to a specific glucocorticoid receptor (GR) that on activation translocates to the nucleus and either increases (transactivates) or decreases (transrepresses) the expression of responsive genes. Transrepression is the major mechanism of glucocorticoid action in inhibiting inflammatory gene expression. Thus, the ability of the transcription factors AP-1 and NF-kappaB to induce gene transcription is attenuated by GR. Although only 5-10% of asthmatic subjects are glucocorticoid-insensitive, these subjects account for over 50% of the health-care costs for asthma (> $6 billion per annum). Examining these patients also gives an insight into important aspects of glucocorticoid action in controlling inflammation and into the development of potential new drugs. Biochemical and genomic studies have indicated abnormal induction of the c-Jun N-terminal kinase (JNK) pathway in some of these patients. The ability of most patients to respond to dexamethasone with induction of histone acetylation correlated with nuclear translocation of GR. However, a subgroup of these patients had an inability to correctly interact with the basal transcription complex in spite of high levels of nuclear GR. This suggests that cross-talk between pro- and anti-inflammatory transcription factors may modulate activation of the transcriptional complex and thereby reduce steroid actions.

摘要

哮喘是一种气道慢性炎症性疾病,其特征为细胞浸润和激活。这些过程由趋化因子和细胞因子的过表达所诱导,如嗜酸性粒细胞趋化因子、白细胞介素-1β和粒细胞-巨噬细胞集落刺激因子。这些介质是转录因子激活蛋白-1(AP-1)和核因子-κB(NF-κB)的下游靶点,它们控制着大多数免疫调节基因的表达,且其活性和表达在哮喘中升高。糖皮质激素是用于治疗哮喘等慢性炎症性疾病的最有效抗炎药物。它们通过与特定的糖皮质激素受体(GR)结合发挥作用,该受体激活后易位至细胞核,可增加(反式激活)或减少(反式抑制)反应性基因的表达。反式抑制是糖皮质激素抑制炎症基因表达作用的主要机制。因此,转录因子AP-1和NF-κB诱导基因转录的能力被GR减弱。虽然只有5%至10%的哮喘患者对糖皮质激素不敏感,但这些患者占哮喘医疗费用的50%以上(每年超过60亿美元)。研究这些患者也有助于深入了解糖皮质激素在控制炎症方面的重要作用以及潜在新药的研发。生化和基因组学研究表明,其中一些患者的c-Jun氨基末端激酶(JNK)途径存在异常诱导。大多数患者用地塞米松诱导组蛋白乙酰化的反应能力与GR的核转位相关。然而,这些患者中的一个亚组尽管细胞核内GR水平较高,但无法与基础转录复合物正确相互作用。这表明促炎和抗炎转录因子之间的相互作用可能调节转录复合物的激活,从而降低类固醇的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验